Description
A KCC2 inhibitor (IC50 = 568 nM); selectively inhibits KCC2 over NKCC1 (IC50 = >50 µM) but does inhibit the activity of adenosine A1 and A3 receptors, as well as inhibits activity of L-type calcium channels at the benzothiazepine site and hERG potassium channels by >50% in a panel at 10 µM; decreases potassium ion uptake by 70% in HEK293 cells expressing KCC2 at 1 µM
Formal name: N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]-acetamide
Synonyms:
Molecular weight: 342.4
CAS: 893990-34-6
Purity: ≥98%
Formulation: A crystalline solid